You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Details for Patent: 10,426,787

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 10,426,787 protect, and when does it expire?

Patent 10,426,787 protects DUOBRII and is included in one NDA.

This patent has twenty-six patent family members in nineteen countries.

Summary for Patent: 10,426,787

Title:	Topical compositions and methods for treating psoriasis
Abstract:	Topical pharmaceutical compositions comprise a combination of a corticosteroid and a retinoid; and methods for treating psoriasis with same. In one embodiment, the corticosteroid comprises halobetasol propionate, and the retinoid comprises tazarotene.
Inventor(s):	Dow; Gordon J. (Greenbrae, CA), Pillai; Radhakrishnan (Santa Rosa, CA), Bhatt; Varsha D. (San Francisco, CA)
Assignee:	Bausch Health US, LLC (Bridgewater, NJ)
Application Number:	15/903,785
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 10,426,787
Patent Claim Types: see list of patent claims	Use; Composition;

Drugs Protected by US Patent 10,426,787

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Bausch	DUOBRII	halobetasol propionate; tazarotene	LOTION;TOPICAL	209354-001	Apr 25, 2019		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				TOPICAL TREATMENT OF PLAQUE PSORIASIS IN ADULTS	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 10,426,787

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2016279801	⤷ Try a Trial
Brazil	112017027332	⤷ Try a Trial
Brazil	112019023817	⤷ Try a Trial
Canada	2988577	⤷ Try a Trial
Canada	3063371	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.